4-[2-(Hydroxymethyl)-8-{[4-(4-phenylbutoxy)benzoyl]amino}-2,3-dihydro-4H-1,4-benzoxazin-4-yl]butanoic acid

ID: ALA3403184

Chembl Id: CHEMBL3403184

PubChem CID: 118729613

Max Phase: Preclinical

Molecular Formula: C30H34N2O6

Molecular Weight: 518.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCCN1CC(CO)Oc2c(NC(=O)c3ccc(OCCCCc4ccccc4)cc3)cccc21

Standard InChI:  InChI=1S/C30H34N2O6/c33-21-25-20-32(18-7-13-28(34)35)27-12-6-11-26(29(27)38-25)31-30(36)23-14-16-24(17-15-23)37-19-5-4-10-22-8-2-1-3-9-22/h1-3,6,8-9,11-12,14-17,25,33H,4-5,7,10,13,18-21H2,(H,31,36)(H,34,35)

Standard InChI Key:  NQJREPQHJNEAAW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3403184

    ---

Associated Targets(Human)

CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYSLTR2 Tchem Cysteinyl leukotriene receptor 2 (135 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.61Molecular Weight (Monoisotopic): 518.2417AlogP: 4.77#Rotatable Bonds: 13
Polar Surface Area: 108.33Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.18CX Basic pKa: 1.68CX LogP: 4.96CX LogD: 1.91
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: -0.49

References

1. Itadani S, Takahashi S, Ima M, Sekiguchi T, Aratani Y, Egashira H, Matsumura N, Inoue A, Yonetomi Y, Fujita M, Nakayama Y, Takeuchi J..  (2015)  Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid.,  23  (9): [PMID:25800431] [10.1016/j.bmc.2015.03.011]

Source